Company Filing History:
Years Active: 2023
Title: Quaisar Ali: Innovator in Pharmaceutical Chemistry
Introduction
Quaisar Ali is a notable inventor based in Franklin Square, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Quaisar Ali holds a patent for "Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors." This invention provides compounds with a specific formula and pharmaceutically acceptable salts. The patent outlines pharmaceutical compositions and methods for treating various conditions or diseases where inhibiting ROCK1, ROCK2, or both has therapeutic benefits. He has 1 patent to his name.
Career Highlights
Quaisar Ali is currently associated with Angion Biomedica Corporation, where he applies his expertise in drug development and innovation. His work focuses on creating effective treatments that can improve patient outcomes.
Collaborations
Throughout his career, Quaisar has collaborated with talented professionals, including An-Hu Li and Dibyendu Dana. These partnerships have contributed to the advancement of his research and the successful development of new pharmaceutical solutions.
Conclusion
Quaisar Ali's innovative work in the field of pharmaceutical chemistry exemplifies the impact of targeted research on healthcare. His contributions continue to pave the way for new treatments and advancements in medicine.